OSHA AI Agent
Get instant answers to any safety question.
Request Demo
OSHA 1910.1200AppA

Health hazard classification criteria

Subpart Z

50 Questions & Answers
10 Interpretations

Questions & Answers

Under 1910.1200 App A A.0.1.1: What does the term "hazard classification" mean when classifying health hazards of chemicals?

Hazard classification means you consider only the intrinsic hazardous properties of the chemical itself.

Under 1910.1200 App A A.0.1: What are the three basic steps required for hazard classification of a chemical?

The three basic steps are: identify relevant hazard data; review that data to determine hazards; and decide whether and how the chemical should be classified.

Under 1910.1200 App A A.0.1.2: Do the classification criteria always give numeric cutoffs, or is expert judgment sometimes required?

Expert judgment is sometimes required because many hazard classes use semi-quantitative or qualitative criteria that need interpretation.

  • The appendix explains that for many hazard classes the criteria are not purely numeric and classifiers must use expert judgment; see 1910.1200 App A A.0.1.2 and the main 1910.1200.

Under 1910.1200 App A A.0.2.1: Is there a requirement to perform new tests before classifying a chemical?

No—there is no requirement to perform new testing to classify a chemical.

Under 1910.1200 App A A.0.2.2–A.0.2.3: Can any scientifically validated test method be used for hazard classification?

Yes—any test method that is scientifically validated and yields reliable, relevant results may be used for classification.

  • The appendix states the criteria are test-method neutral and that "scientifically validated" methods establishing reliability and relevance are acceptable; see 1910.1200 App A A.0.2.2–A.0.2.3 and the main 1910.1200.

Under 1910.1200 App A A.0.2.5: Can a chemical be excluded from classification if data show it is not biologically available?

Yes—if conclusive experimental data from scientifically validated methods show the chemical is not biologically available, it need not be classified.

  • The appendix explains that lack of biological availability supported by conclusive data can justify not classifying the chemical; see 1910.1200 App A A.0.2.5 and the primary 1910.1200.

Under 1910.1200 App A A.0.2.6: Should human data such as epidemiology be used in hazard classification?

Yes—epidemiological and occupational experience data must be considered when evaluating human health hazards.

Under 1910.1200 App A A.0.3.1–A.0.3.5: How should conflicting animal and human data be handled in a weight-of-evidence classification?

Conflicting data must be evaluated by weighing quality, consistency, and relevance; reliable human data generally take precedence but robust animal data can justify classification when human data are limited.

  • The appendix describes a weight-of-evidence approach considering all valid in vitro, animal, and human data and says reliable human data usually have precedence; see 1910.1200 App A A.0.3.1–A.0.3.5 and 1910.1200.

Under 1910.1200 App A A.0.3.4: Can mechanistic or mode-of-action data change a classification?

Yes—if mechanistic or metabolism studies show an effect is not relevant to humans, the classifier may lower the classification or not classify the chemical.

  • The appendix states that route of exposure and mechanism data are pertinent and that demonstrated non-relevance to humans supports not classifying; see 1910.1200 App A A.0.3.4 and 1910.1200.

Under 1910.1200 App A A.0.3.6: Can a single good-quality animal study justify classification?

Yes—a single well-designed, scientifically sound animal study with statistically and biologically significant results can be sufficient to justify classification.

Under 1910.1200 App A A.0.4.1–A.0.4.3: What order of precedence applies when classifying mixtures?

Classify a mixture based on (1) test data for the mixture if available; (2) bridging principles for similar mixtures if mixture data are not available; or (3) ingredient-based estimation methods (e.g., cut-off values) if neither mixture data nor bridging are available.

Under 1910.1200 App A A.0.4.2: Are there hazard classes for which mixtures must be classified using ingredient information first?

Yes—Carcinogenicity, Germ Cell Mutagenicity, and Reproductive Toxicity require classification based on ingredient information unless a case-by-case justification supports classifying the whole mixture.

Under 1910.1200 App A A.0.4.3.2: If an ingredient poses a hazard below its cut-off concentration, must the mixture still be classified for that hazard?

Yes—if you have information showing the ingredient’s hazard is present below the cut-off, you must classify the mixture accordingly.

  • The appendix requires classifiers to use available information showing hazards below cut-off values and to classify the mixture when appropriate; see 1910.1200 App A A.0.4.3.2 and 1910.1200.

Under 1910.1200 App A A.0.4.3.3: Can conclusive data showing lack of hazard above a cut-off allow you to avoid classifying a mixture?

Yes—in exceptional cases conclusive data can demonstrate that an ingredient above the cut-off does not present a hazard in the mixture, allowing classification based on those data.

  • The appendix permits this only when data exclude the possibility that the ingredient will behave differently in the mixture; see 1910.1200 App A A.0.4.3.3 and 1910.1200.

Under 1910.1200 App A A.0.4.4: When can antagonistic effects be used to lower a mixture’s classification?

Antagonistic effects can be used to lower classification only if supported by sufficient data demonstrating reduced hazard in the mixture.

  • The appendix directs evaluators to consider synergistic or antagonistic interactions and allows lowering classification for antagonism only when adequately supported by data; see 1910.1200 App A A.0.4.4 and 1910.1200.

Under 1910.1200 App A A.0.5.1.1 (Dilution): If a tested mixture is diluted with a non-toxic diluent, how should the diluted mixture be classified?

The diluted mixture may be classified as equivalent to the tested mixture if the diluent has equal or lower toxicity and does not affect other ingredients’ toxicity; for acute toxicity you may alternatively use the additivity formula in A.1.3.6.

Under 1910.1200 App A A.0.5.1.2 (Batching): When is it acceptable to assume an untested production batch has the same toxicity as a tested batch?

It is acceptable when the untested batch is produced by or under the control of the same chemical manufacturer and there is no reason to believe significant variation has changed toxicity.

Under 1910.1200 App A A.0.5.1.3–A.0.5.1.4: How do concentration changes and interpolation affect classification of untested mixtures?

If a tested mixture is Category 1 and the concentration of Category 1 ingredients increases, the untested mixture must be Category 1; if an untested mixture has ingredient concentrations between two tested mixtures that are in the same hazard category, you may interpolate and assign the same category.

Under 1910.1200 App A A.0.5.1.5: What does "substantially similar mixtures" mean for assigning the same classification?

Substantially similar mixtures are those that share ingredients with essentially the same concentrations and where the available toxicity data for differing ingredients are substantially equivalent; if one mixture of such a pair is classified based on test data, the other can be assigned the same hazard category.

Under 1910.1200 App A A.0.5.1.6 (Aerosols): If a non-aerosol mixture has been tested, how should its aerosol form be classified?

An aerosol form shall be classified in the same hazard category as the tested non-aerosol form provided the added propellant does not affect toxicity when spraying.

Under 1910.1200 App A A.1.1–A.1.2: What is "acute toxicity" and how are substances categorized?

Acute toxicity refers to serious adverse effects (including lethality) after a single or short-term exposure, and substances are placed into four numeric hazard categories for oral, dermal, or inhalation routes using the cut-off criteria in Table A.1.1.

Under 1910.1200AppA Table A.1.1, what Acute Toxicity Estimate (ATE) ranges define the oral acute toxicity hazard Categories 1–4?

Category limits for oral acute toxicity are based on the acute toxicity estimate (ATE) in mg/kg bodyweight: Category 1 ATE ≤ 5; Category 2 > 5 and ≤ 50; Category 3 > 50 and ≤ 300; Category 4 > 300 and ≤ 2000. See Table A.1.1 in 1910.1200AppA for the official values and footnotes.

Under 1910.1200AppA, what ATE ranges define dermal, inhalation (gases), inhalation (vapors), and inhalation (dusts and mists) Categories 1–4?

Each exposure route has its own ATE ranges for Categories 1–4: for dermal (mg/kg) Category 1 ATE ≤ 50; Category 2 > 50 ≤ 200; Category 3 > 200 ≤ 1000; Category 4 > 1000 ≤ 2000. For inhalation gases (ppmV) Category 1 ATE ≤ 100; Category 2 > 100 ≤ 500; Category 3 > 500 ≤ 2500; Category 4 > 2500 ≤ 20000. For inhalation vapors (mg/L) Category 1 ATE ≤ 0.5; Category 2 > 0.5 ≤ 2.0; Category 3 > 2.0 ≤ 10.0; Category 4 > 10.0 ≤ 20.0. For inhalation dusts and mists (mg/L) Category 1 ATE ≤ 0.05; Category 2 > 0.05 ≤ 0.5; Category 3 > 0.5 ≤ 1.0; Category 4 > 1.0 ≤ 5.0. These ranges are listed in Table A.1.1 in 1910.1200AppA.

How should inhalation toxicity data generated at 1‑hour exposure be converted for use with the 4‑hour cutoffs in 1910.1200AppA?

Convert 1‑hour inhalation test results to 4‑hour equivalents by dividing by the appropriate factor: divide by 2 for gases and vapors, and divide by 4 for dusts and mists. This conversion method is specified in 1910.1200AppA where inhalation conversion factors are discussed.

Under 1910.1200AppA, how are the terms 'dust', 'mist', and 'vapor' defined for inhalation classification?

For classification purposes: “dust” means solid particles suspended in a gas (usually air); “mist” means liquid droplets suspended in a gas (usually air); and “vapor” means the gaseous form of a substance released from its liquid or solid state. These definitions appear in 1910.1200AppA in the discussion of inhalation routes.

Which animal species are preferred for acute toxicity testing by oral, dermal, and inhalation routes under 1910.1200AppA?

The preferred species are the rat for oral and inhalation acute toxicity testing, and the rat or rabbit for acute dermal toxicity testing. [1910.1200AppA] (https://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1200#1910.1200AppA) states these preferences and indicates that when multiple species data exist, scientific judgment should be used to select the most appropriate LD50 or LC50.

Can human exposure or epidemiology data be used when classifying acute toxicity under 1910.1200AppA?

Yes — human experience (occupational data, accident databases, clinical reports, epidemiology) should be considered as part of a weight‑of‑evidence approach when available. 1910.1200AppA specifically directs classifiers to consider human data along with animal and in vitro evidence.

Under 1910.1200AppA, when should a classifier assess whether a substance is corrosive to the respiratory tract and how does that affect labeling?

If available data indicate inhalation effects are due to corrosivity, the classifier must consider whether the chemical is corrosive to the respiratory tract; if the corrosive effect can cause lethality, label the chemical with the "corrosive to the respiratory tract" hazard statement and use the corrosive pictogram. 1910.1200AppA explains how corrosivity is evaluated and how corrosive respiratory effects must be communicated.

What evidence may be used to evaluate respiratory corrosivity under 1910.1200AppA?

Evaluation of respiratory corrosivity may be based on expert judgment using human and animal experience, in vitro data, pH values, data from similar substances, or any other pertinent information. Guidance for this evaluation and its labeling consequences are found in 1910.1200AppA.

Under 1910.1200AppA A.1.3, how are "relevant ingredients" of a mixture defined for acute toxicity classification?

Relevant ingredients are those present at concentrations ≥ 1% (weight/weight for solids, liquids, dusts, mists and vapors; volume/volume for gases). An ingredient below 1% must still be considered if there is reason to suspect it will affect the mixture’s acute toxicity. This definition is in 1910.1200AppA A.1.3.3.

When classifying a mixture for acute toxicity, is it necessary to classify every route of exposure under 1910.1200AppA?

No — classification of a mixture for acute toxicity must be carried out for each route of exposure only when relevant evidence indicates toxicity by multiple routes; otherwise, one route may be used provided that route (estimated or tested) is followed for all ingredients. 1910.1200AppA A.1.3.2 describes this requirement and states the pictogram/signal word must reflect the most severe hazard identified.

If a mixture has been tested as a whole, how should it be classified under 1910.1200AppA?

If acute toxicity test data exist for the complete mixture, classify the mixture using the same criteria as for substances (Table A.1.1). 1910.1200AppA A.1.3.4 directs that tested mixtures be classified according to Table A.1.1.

How do you calculate an ATE for a mixture from ingredient ATEs when data are available for all ingredients under 1910.1200AppA?

Calculate the mixture ATE using the additivity formula: 100 / ATE_mix = sum over ingredients of (C_i / ATE_i), where C_i is the concentration (%) of ingredient i and ATE_i is its acute toxicity estimate. The formula and explanation are given in 1910.1200AppA A.1.3.6.1 and the associated figure.

What should you do under 1910.1200AppA if one or more ingredients in a mixture lack an ATE?

If an ingredient lacks an ATE, first see if a reliable derived conversion value can be obtained (e.g., from extrapolation, human evidence, other assays, or structure‑activity analogs) and then apply the additivity formula; if reliable estimation is not possible and an ingredient ≥1% has unknown acute toxicity, you cannot assign a definitive ATE for the mixture and must follow the provisions in A.1.3.6.2.4. 1910.1200AppA A.1.3.6.2 explains these steps and the need for expert technical information when deriving estimates.

When all ingredient acute toxicity point estimates fall in the same category, how should the mixture be classified under 1910.1200AppA?

If converted acute toxicity point estimates for all ingredients are within the same category, then the mixture should be classified in that same category. This rule is stated in 1910.1200AppA A.1.3.3(c).

When only range data or hazard-category information are available for ingredients, how can those be used to classify a new mixture under 1910.1200AppA?

When only range (e.g., LD50 range) or hazard‑category data are available for ingredients, they may be converted to point estimates using the conversion guidance in Table A.1.2 of 1910.1200AppA, and those point estimates can then be used in the additivity calculation described in A.1.3.6.1.

Under 1910.1200AppA, how do I classify a mixture when some ingredients have unknown acute (oral/dermal/inhalation) toxicity and their total concentration is ≤ 10%?

Classify the mixture based only on the known ingredients, but you must use the formula in A.1.3.6.1 when the total of relevant unknown-toxicity ingredients is ≤ 10%.

  • The appendix states that "the mixture is classified based on the known ingredients only" while also specifying that when the total concentration of relevant ingredient(s) with unknown acute toxicity is ≤ 10% the formula in A.1.3.6.1 must be used to determine hazard category.
  • You must also include a statement on the label and safety data sheet that X percent of the mixture consists of ingredient(s) of unknown acute toxicity (see 1910.1200AppA and appendices C and D).

Under 1910.1200AppA, what do I do when relevant ingredients with unknown acute toxicity make up > 10% of a mixture?

When unknown-acute-toxicity ingredients total more than 10% of the mixture, adjust the A.1.3.6.1 formula to correct for the percent unknown as shown in the appendix and used to calculate the mixture's acute toxicity estimate.

  • Appendix A explains that if "the total concentration of the relevant ingredient(s) with unknown acute toxicity is >10%," you must use the corrected formula shown in A.1.3.6.1 (adjusted for % unknown) (the document presents the adjusted formula graphically).
  • Also remember to declare the percent of ingredients of unknown acute toxicity on the label and safety data sheet as required in 1910.1200AppA and see appendices C and D for allocation of label elements and SDS requirements.

Under 1910.1200AppA Table A.1.2, what acute toxicity point estimates should I use when converting hazard category or range values for a mixture classification?

Use the point estimates given in Table A.1.2 to convert experimentally obtained acute toxicity ranges or hazard categories into Acute Toxicity Estimate (ATE) point values for the classification formulas.

  • For example, Table A.1.2 converts oral Category 1 (≤ 5 mg/kg) to an ATE of 0.5 mg/kg, Category 2 (5–50 mg/kg) to 5 mg/kg, Category 3 (50–300 mg/kg) to 100 mg/kg, and Category 4 (300–2000 mg/kg) to 500 mg/kg. Similar conversion rows are provided for dermal, gases, vapors, and dust/mist. See Table A.1.2 for the full list of conversions.
  • Apply those point estimates in the mixture classification formulas found in 1910.1200AppA.

Under 1910.1200AppA A.2.1.3, what is the 'tiered approach' for skin corrosion/irritation classification and how should I use it?

The tiered approach organizes available skin corrosion/irritation information into sequential levels so you can classify based on the highest-quality consistent data or use weight-of-evidence when results conflict.

  • Appendix A states that a tiered approach (see A.2.1.3) "organizes the available information into levels/tiers and provides for decision-making in a structured and sequential manner."
  • Proceed from the highest-priority data (reliable human data), to standard animal test data, to validated in vitro/ex vivo tests, then to other animal data, chemical properties, and non-test methods, applying classification as soon as consistent criteria are met; when information within a tier is inconsistent use the weight-of-evidence within that tier (see 1910.1200AppA).

Under 1910.1200AppA A.2.2.1, can reliable human data be used to classify skin corrosion or irritation?

Yes — reliable, good-quality human data should be given high weight and can be used to classify skin corrosion or irritation.

  • Appendix A explicitly states that "existing reliable and good quality human data on skin corrosion/irritation should be given high weight for classification," including well-documented occupational, clinical, or epidemiological observations (A.2.2.1).
  • However, absence of reported incidents in human data is not proof that classification is unnecessary because exposures and reporting can be uncertain (see 1910.1200AppA).

Under 1910.1200AppA A.2.2.2 and Table A.2.1, how are skin corrosion subcategories 1A, 1B, and 1C determined from animal tests?

Subcategories are based on the speed and extent of corrosive responses in validated animal tests (OECD TG 404 criteria summarized in Table A.2.1).

  • Table A.2.1 in Appendix A explains: sub-category 1A is assigned when corrosive responses occur in at least one animal following exposure ≤ 3 minutes (observations ≤ 1 hour); 1B is for responses after > 3 minutes and ≤ 1 hour (observations ≤ 14 days); 1C is for responses after > 1 hour and ≤ 4 hours (observations ≤ 14 days). See Table A.2.1 and A.2.2.2 for details.
  • These criteria apply when classifying based on standard animal test data, such as studies conducted according to OECD TG 404 (1910.1200AppA).

Under 1910.1200AppA, what are the animal-test criteria for assigning Skin Irritation (Category 2)?

A substance is Category 2 (irritant) when animal test results meet the specific mean-score or persistence criteria described in Table A.2.2.

  • Table A.2.2 gives three alternative criteria: (1) a mean score ≥ 2.3 and ≤ 4.0 for erythema/eschar or edema in at least 2 of 3 tested animals at 24, 48, and 72 hours (or on 3 consecutive days if delayed); (2) inflammation that persists to the end of the observation period (normally 14 days) in at least 2 animals (considering alopecia, hyperkeratosis, hyperplasia, scaling); or (3) pronounced variability where a single animal shows a very elevated consistent response attributable to exposure. See Table A.2.2 and A.2.2.2.2 for full guidance.

Under 1910.1200AppA A.2.2.3, can validated in vitro or ex vivo tests be used for skin corrosion or irritation classification, and what limits apply?

Yes — validated in vitro/ex vivo methods can be used for classification when the test method is internationally accepted and the substance is within the method's applicability domain; sometimes more than one method is needed.

  • Appendix A states that where possible classification should be based on data generated using internationally validated methods (e.g., OECD TGs) and that individual in vitro/ex vivo methods address either corrosion or irritation but not both, so more than one test method may be required (A.2.2.3).
  • Specifically, OECD TGs 430, 431, or 435 can support skin corrosion classification (see A.2.2.3.3.1), and OECD TG 439 can support skin irritation classification (see A.2.2.3.4.1).
  • If an in vitro result excludes corrosivity (e.g., a validated negative in TG 431) you can classify as not corrosive, and a negative in TG 439 can support not classified for irritation; always confirm that the test method is applicable to your substance.

Under 1910.1200AppA A.2.2.4, can skin observations from acute toxicity studies be used to classify skin corrosion/irritation?

Yes — observations of skin corrosion/irritation made during acute toxicity studies can be used for classification provided the study conditions (dilutions and species) are relevant.

  • Appendix A explains that when skin effects are observed in acute toxicity studies, those data may be used for classification if the dilutions used and species tested are appropriate to the endpoint (A.2.2.4).
  • Be aware that for substances highly toxic via the dermal route, a dedicated in vivo skin corrosion/irritation study may not have been performed because required doses could cause systemic toxicity; in such cases consider other relevant data sources in the tiered scheme (1910.1200AppA).

Under 1910.1200AppA A.2.2.5, can a substance be classified as corrosive based solely on pH, and what pH values trigger that presumption?

Yes — in the absence of other information, substances with extreme pH are presumed corrosive: pH ≤ 2 or pH ≥ 11.5 normally leads to Skin Category 1 unless buffering/acid–alkaline reserve indicates otherwise.

  • Appendix A states that "a substance is considered corrosive (Skin Category 1) if it has a pH ≤ 2 or a pH ≥ 11.5" in the absence of other data, while noting that buffering capacity (acid/alkaline reserve) can alter the expected effect and should be confirmed by additional data, preferably a validated in vitro/ex vivo test (see A.2.2.5).
  • Buffering capacity and pH can be determined by appropriate test methods including OECD TG 122, and if buffering suggests non-corrosivity, verify with validated test data before changing classification.

Under 1910.1200AppA A.2.2.6, may non-test methods be used for skin corrosion/irritation classification?

Yes — non-test methods can be used on a case-by-case basis if their reliability and applicability are considered carefully.

  • Appendix A allows classification (including non-classification) based on non-test methods, but emphasizes that reliability and applicability must be evaluated on a case-by-case basis (A.2.2.6).
  • Use non-test methods only when they are scientifically justified and consistent with the tiered/weight-of-evidence approach in 1910.1200AppA.

Under 1910.1200AppA A.2.2.3.3, what if validated in vitro/ex vivo tests cannot distinguish subcategories 1B versus 1C for skin corrosion?

If in vitro/ex vivo data cannot distinguish between subcategories 1B and 1C, use additional information to differentiate; if no sufficient additional information exists, classify the substance as Category 1 (uncategorized).

  • Appendix A states that when existing in vitro/ex vivo data cannot distinguish between sub-categories, additional information must be taken into account to differentiate them, and "where no or insufficient additional information is available, category 1 is applied" (A.2.2.3.3).
  • Therefore, seek relevant animal data, reliable human data, chemical properties (e.g., pH and buffering), or other valid information before defaulting; if none are adequate, apply Category 1 in accordance with 1910.1200AppA.

Under 1910.1200AppAA.2.2.6.2, when can I use read-across (analogue or category approaches) instead of new testing to classify a substance for skin corrosion/irritation?

You may use read-across when you have sufficiently reliable test data on similar substance(s) and you can justify that the tested substance(s) are similar enough to the untested substance to support the classification—when that justification is adequate, read‑across generally carries more weight than (Q)SAR predictions.

  • Required elements: reliably conducted test data on analogue(s) and a clear scientific justification showing similarity (toxicity profile, chemical structure, mode of action, and other relevant properties). See the read-across requirements in A.2.2.6.2.
  • Relationship to (Q)SARs: read-across usually has higher weight than (Q)SAR results when well justified; by contrast, classification based on (Q)SARs requires sufficient data and model validation using internationally recognized validation principles—lack of an alert in a SAR/expert system is not enough to conclude no hazard. See guidance on (Q)SARs in A.2.2.6.3.
  • Practical checklist before using read-across:
    • Confirm test methods and data quality for the analogue(s) are adequate and reliable.
    • Provide mechanistic or structural rationale that the analogue(s) predict the target substance’s effect.
    • Document any uncertainties and why read‑across is preferred over (Q)SARs or additional testing.

For more on applying initial information in a structured way, consider the tiered approach described in A.2.2.7 which emphasizes human/animal data first, then in vitro/ex vivo data, and then non‑test methods like read‑across.

Under 1910.1200AppAA.2.3.3 and Tables A.2.3/A.2.4, how do I classify a mixture for skin corrosion/irritation when I only have data for the ingredients?

Use the additivity (ingredient-based) approach: identify the "relevant ingredients" (usually those ≥1%), apply the prescribed weighting rules (10× for some corrosive ingredients below the Category 1 limit), and compare the weighted sums to the cut‑off values in Table A.2.3; if the additivity approach cannot be applied (e.g., strong acids/bases or certain chemistries), use the special rules in Table A.2.4 (including pH criteria).

  • Identify relevant ingredients: treat as "relevant" any ingredient present at ≥1% (w/w for solids/liquids, v/v for gases); also include any ingredient <1% if you have reason to suspect it affects classification. See definition and guidance in A.2.3.3.1/.3.3.6.
  • Apply additivity and weighting: corrosive and irritant ingredients contribute proportionally to the mixture’s hazard. A weighting factor of 10 is applied to corrosive ingredients that are present below the concentration limit for Category 1 but still contribute to irritation classification; then compare sums to the concentration cut‑offs. See A.2.3.3.2 and A.2.3.3.3.
  • Use Table A.2.3 triggers (summary):
    • Sum of Skin Category 1 ingredients ≥5% → classify the mixture as Skin Category 1.
    • Sum of Skin Category 2 ingredients ≥10% → classify the mixture as Skin Category 2.
    • If (10 × Skin Category 1) + Skin Category 2 ≥10% → classify as Skin Category 2 (i.e., 1‑category ingredients get 10× weighting for irritancy calculations). (See Table A.2.3 in A.2.3.3.3.)
  • Special cases where additivity does not work: for mixtures with strong acids/bases, inorganic salts, aldehydes, phenols, surfactants, or other chemistries where concentration rules are unreliable, use pH-based or specific cutoffs from Table A.2.4—for example, an acid with pH ≤2 at ≥1% or a base with pH ≥11.5 at ≥1% requires classification as Skin Category 1. See Table A.2.4 and related text in A.2.3.3.4.
  • Extra notes:
    • If reliable data show an ingredient causes skin effects at concentrations below the generic cut‑offs (<1% for corrosives or <3% for irritants), classify the mixture accordingly (see A.2.3.3.6).
    • Where sub‑categorization of Category 1 is used, ensure the sum for each sub‑category (1A/1B/1C) meets the ≥5% threshold to classify that sub‑category; otherwise apply the rules for combined sub‑categories as explained in the Appendix (see A.2.3.3.3 note).

For the full decision logic and examples, consult the mixture classification section in A.2.3 of the Appendix to 1910.1200.